Ocular Drug Delivery Solutions

  1. Concept Development and DFM

    A Blueprint for Success

    West believes that getting involved in the very early phases of product development enables the West team of experts to optimize your product design.  This philosophy has proven to yield significant short-term and long-term benefits.  Getting involved early improves cycle times, identifies the right materials for your specific application, lowers scrap, lowers capital costs and lowers long-term maintenance costs.  

  2. Assembly Solutions: Medical, Drug Delivery And Diagnostic Devices

    Where It All Comes Together

    The West Contract Manufacturing team provides quality value-added assembly for almost any medical device, drug delivery device or diagnostic device. West contract manufacturing sites have significant and broad-based experience with assembling these types of specialized products. The team’s experience ranges from multi-component, complex assemblies that are manually assembled to high-speed assembly systems built by some of the world’s leading automation integrators.

  3. The Future Of Glass Packaging Is Here

    Review the potential of Corning Valor® Glass to optimize the fill/finish process and reduce total cost of quality as well as overall manufacturing cost.

  4. Robotic Multi-Format Filling & Closing System 1/2/2020

    AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

  5. Blow-Fill-Seal Packaging Systems For Large Volume Nebulizers And Humidifiers 7/9/2020

    Large volume humidifiers and nebulizers – typically in sizes from 250 – 1000mL – can be specifically designed to fit existing delivery devices. Custom designs to facilitate the control of humidification in oxygen delivery can be developed.

  6. Blow/Fill/Seal Packaging Systems 7/9/2020

    Weiler Engineering’s ASEP-TECH® Blow/Fill/Seal machines are ideal for processing temperature sensitive products such as biological and protein-based materials – providing a level of enhanced sterility assurance.

  7. Injection Molding 8/24/2020

    Capabilities that improve efficiency and accelerate development.

    B. Braun's OEM Division offers a variety of in-house molding capabilities including injection molding, insert molding and over molding. They own a primary 400,000-square-foot U.S. plant that includes a 16,500-square-foot ISO Class 8 molding facility housing some of B. Braun’s 80 injection molding presses, which range from 55-330 tons.

  8. Isolator Barrier Pharmaceutical Aseptic Filling Systems 11/12/2020

    ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.

  9. Patient-Centric Drug Delivery Device 2/10/2021

    ArQ is built around our primary cyclic olefin copolymer (COC) drug container. It offers an autoinjector that is simple to use, with the flexibility and ability to deliver a wide range of viscosities and volumes.

  10. Small, Simple-To-Use Package For Delivering High-Viscosity Formulations 2/10/2021

    Subcutaneous

    Low - Medium Viscosities
    < 100 cP
    1 - 10 ml

    High - Ultra-High Viscosities
    >100 - 10,000 cP
    0.5 - 3 ml

    ArQ® - Bios offers a small, simple to use package to deliver high viscosity formulations. Oval’s proprietary COC PDC technology allows us to build the device around a stronger drug container that can deliver 1ml of formulations up to 1000cP through a 25G needle in  less than 5 seconds. The ArQ-Bios  platform  also can deliver  greater volumes than 1 ml subject to matching  the formulation characteristics with acceptable patient tolerability.